BONE BIOLOGICS CORP (BBLG) Stock Income Statement
NASDAQ:BBLG - Nasdaq - US0980705018 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Gross Profit | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 4.22M | 9.43M | 3.67M | 1.10M | 830.00K | |||
| Research and Development | 2.13M | 6.91M | 1.58M | 80.00K | 340.00K | |||
| Selling, General, and Administrative Expenses | 2.09M | 2.52M | 2.09M | 1.02M | 480.00K | |||
| Operating Income | -4.22M | -9.43M | -3.67M | -1.10M | -830.00K | |||
| Interest Income/Expense | 55.70K | 1.90K | 0.00 | -810.00K | -1.00M | |||
| Other Income/Expense | 51.10K | 892.70K | 2.18M | 300.00K | N/A | |||
| Non Recurring Items | 0.00 | -415.00K | N/A | N/A | N/A | |||
| Income Before Taxes | -4.11M | -8.95M | -1.48M | -1.61M | -1.82M | |||
| Income Tax | N/A | N/A | N/A | 1.60K | 0.00 | |||
| Net Income | -7.32M | -8.95M | -1.48M | -1.61M | -1.82M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.83 | -34.01 | -3.90 | -10.73 | -18.20 | |||
| Non GAAP EPS | N/A | -66.39 | -50.40 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD